Target intelligence / Profile preview

CD68 molecule (CD68)

Target
CD68
Molecular classification
Lysosomal/endosomal-associated membrane glycoprotein (LAMP) family, Scavenger receptor family, CD molecule, Type I transmembrane glycoprotein
01

Overview

CD68 molecule (commonly abbreviated as CD68) is a heavily glycosylated type I transmembrane glycoprotein of 110 kD, encoded by the CD68 gene on chromosome 17[1][5]. It is primarily localized to lysosomes and endosomes, with a portion present on the plasma membrane[1][4]. CD68 is highly expressed in the monocyte-macrophage lineage, including tissue macrophages (such as Kupffer cells and microglia), monocytes, osteoclasts, and some dendritic cells[1][4]. It belongs to both the lysosome-associated membrane glycoprotein (LAMP) family and the scavenger receptor family, participating mainly in phagocytosis, the clearance of cellular debris, and immune surveillance[1][3][4][5]. CD68 is extensively used as a pan-macrophage marker in research and diagnostics—for example, to assess macrophage infiltration in tumors and sites of inflammation[3][4]. It has roles in inflammation (e.g., rheumatoid arthritis, Crohn disease) and cancer (as a marker for pro-tumoral and immunoregulatory myeloid cells)[3]. It is not generally considered a direct therapeutic target, and no drugs specifically target CD68[4][5]. CD68 antibodies are widely used for immunohistochemistry, flow cytometry, and cytological applications in clinical and research settings[4].

Other names
MacrosialinSCARD1GP110LAMP4Scavenger receptor class D member 1CD68 antigenMacrophage antigen CD68
02

Biological functions

PhagocytosisClearance of cellular debrisRecruitment and activation of macrophagesImmune responseMarker for monocytes and macrophages
03

Disease associations

Cancer (tumor-associated macrophages in cancer progression)Inflammation (including Crohn disease and rheumatoid arthritis)Infectious diseaseGranular cell tumorHistiocytic sarcoma
04

Safety considerations

Non-specificity to macrophages (expression also observed in fibroblasts, endothelial cells, some dendritic cells, and to a much lesser extent, lymphocytes)Not directly considered a drug targetMarker interpretation may be confounded by expression in non-myeloid lineages
05

Biomarkers

Macrophage infiltration marker in tumors and inflammatory diseasesMarker for monocytes and tissue macrophagesUsed for detection of inflammation and tumor-associated macrophages

Beyond the preview

Go deeper on CD68 molecule (CD68).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD68 molecule (CD68).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call